ArticleFrontiers in oncology2024

Case report: Concurrent intrathecal and intravenous pembrolizumab for metastatic melanoma with leptomeningeal disease.

Xiang Dan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.